2024 ICD-10-CM Diagnosis Code C16.3

by

Malignant neoplasm of pyloric antrum

  • C16.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM C16.3 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C16.3 – other international versions of ICD-10 C16.3 may differ.

Applicable To

  • Malignant neoplasm of gastric antrum

The following code(s) above C16.3 contain annotation back-references

 that may be applicable to C16.3:

  • C00-D49  Neoplasms
  • C15-C26  Malignant neoplasms of digestive organs
  • C16  Malignant neoplasm of stomach

Approximate Synonyms

  • Adenocarcinoma, pyloric antrum
  • Cancer of the stomach, pyloric antrum
  • Primary adenocarcinoma of pyloric antrum
  • Primary malignant neoplasm of pyloric antrum

ICD-10-CM C16.3 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 374 Digestive malignancy with mcc
  • 375 Digestive malignancy with cc
  • 376 Digestive malignancy without cc/mcc

Convert C16.3 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change